BBusiness Read More Lilly’s weight-loss pill wins FDA approvalApril 1, 2026  For the first time, regulators have approved a small-molecule pill targeting glucagon-like peptide1 (GLP-1) for weight loss.…
BBusiness Read More Lilly to pour $6.5 billion into GLP-1 pill manufacturing siteSeptember 24, 2025 Â Eli Lilly and Company plans to ramp up production of the active ingredient for a once-daily weight-loss…